Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2016, , 278 - 282, 30.12.2016
https://doi.org/10.5799/jcei.328366

Öz

Kaynakça

  • 1. Sheikh A, Schrepfer S, Stein W, et al. Right atrial mass after primary repair of an atrial septal defect: thrombus masquerading as a myxoma. Ann Thorac Surg 2007; 84:1742-1744.
  • 2. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002;25:1605-1616.
  • 3. Hartier L, Bera J, Delomez M, et al. Free-floating thrombi in right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999;99:2779-2783.
  • 4. Barakat K, Robinson MN, Spurrell RA. Transvenous pacing lead-induced thrombosis: a series of cases with review of the literature. Cardiology 2000; 93:142-148.
  • 5. Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest 2002; 121:806-814.
  • 6. Blann AD, Lip GY. Lip. Atrial Fibrillation and Thrombosis: The Missing Molecular Links. JACC 2013; 61:861-862.
  • 7. Kaskia JC, Arrebola AL. Inflammation and Thrombosis in Atrial Fibrillation. Rev Esp Cardiol 2011; 64 :551-553.
  • 8.Nicolaou N, Becker A, Mc Michael G, Nicolaou V. Giant atrial thrombus presenting as a tumor. Int J Surg Case Reports 2013; 4:62-64.
  • 9. Natarajan A,Tan S, Patel HN, Chukwu C, Harkness A, Harris S. Mass in the Left Atrial Appendage: A Therapeutic Dilemma. Can J Cardiol 2013; 29(10):1329.e13-1329.e15.
  • 10. Yang EH, Moriarty JM, Lluri G, Aboulhosn JA. Giant left atrial appendage mimicking a mediastinal mass in a new diagnosis of atrial septal defect and pulmonic stenosis. Int J Cardiol. 2014; 175 (2):e27–e29.

A Therapeutic Challenge: Management of Atrial Thrombus

Yıl 2016, , 278 - 282, 30.12.2016
https://doi.org/10.5799/jcei.328366

Öz

Introduction: Primary cause of atrial thrombi include atrial fibrillation, foreign bodies inside the atrium such as
catheters and pacemaker leads, emboli of deep venous thrombus and primary or metastatic tumors of the heart. We
review the clinical features, epidemiology, diagnosis and treatment of nine intriguing cases with atrial thrombus.
Methods: This is a retrospective study of nine patients (seven female (78%), two male (33%)) who were diagnosed
with atrial thrombi (average age of 50 ± 12 years) and were treated at the Ondokuz Mayis University, Department of
Cardiovascular Surgery from February 2014 to January 2015. Among them, six patients had atrial fibrillation (one
male, five female), seven patients were suffering from dispne and orthopnoea, five patients were suffering from leg
swelling, seven patients had a history of hypertension and three patients had a history of mitral valve replacement
surgery.
Results: All patients underwent surgery except one. Four patients recovered uneventfully and discharged with oral
anticoagulation (warfarin) therapy (adjusted to maintain an international normalized ratio of INR between two and
three times). Five of nine patients (55%) died after surgery.
Conclusion: The response to the thrombolytic therapy is poor, mostly ineffective and unsafe so it is often
recommended as a bridge to surgery. In patients diagnosed with mechanical mitral valve thrombosis, medical therapy
has the possibility of end organ emboli and also fail to resolve the organised thrombus on the stuck valve. On the
other hand surgery does not always give satisfactory results. J Clin Exp Invest 2016; 7(4): 278-282

Kaynakça

  • 1. Sheikh A, Schrepfer S, Stein W, et al. Right atrial mass after primary repair of an atrial septal defect: thrombus masquerading as a myxoma. Ann Thorac Surg 2007; 84:1742-1744.
  • 2. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002;25:1605-1616.
  • 3. Hartier L, Bera J, Delomez M, et al. Free-floating thrombi in right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999;99:2779-2783.
  • 4. Barakat K, Robinson MN, Spurrell RA. Transvenous pacing lead-induced thrombosis: a series of cases with review of the literature. Cardiology 2000; 93:142-148.
  • 5. Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest 2002; 121:806-814.
  • 6. Blann AD, Lip GY. Lip. Atrial Fibrillation and Thrombosis: The Missing Molecular Links. JACC 2013; 61:861-862.
  • 7. Kaskia JC, Arrebola AL. Inflammation and Thrombosis in Atrial Fibrillation. Rev Esp Cardiol 2011; 64 :551-553.
  • 8.Nicolaou N, Becker A, Mc Michael G, Nicolaou V. Giant atrial thrombus presenting as a tumor. Int J Surg Case Reports 2013; 4:62-64.
  • 9. Natarajan A,Tan S, Patel HN, Chukwu C, Harkness A, Harris S. Mass in the Left Atrial Appendage: A Therapeutic Dilemma. Can J Cardiol 2013; 29(10):1329.e13-1329.e15.
  • 10. Yang EH, Moriarty JM, Lluri G, Aboulhosn JA. Giant left atrial appendage mimicking a mediastinal mass in a new diagnosis of atrial septal defect and pulmonic stenosis. Int J Cardiol. 2014; 175 (2):e27–e29.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Yazısı
Yazarlar

Serkan Burç Deşer

Mustafa Kemal Demirağ Bu kişi benim

Yayımlanma Tarihi 30 Aralık 2016
Yayımlandığı Sayı Yıl 2016

Kaynak Göster

APA Burç Deşer, S., & Demirağ, M. K. (2016). A Therapeutic Challenge: Management of Atrial Thrombus. Journal of Clinical and Experimental Investigations, 7(4), 278-282. https://doi.org/10.5799/jcei.328366
AMA Burç Deşer S, Demirağ MK. A Therapeutic Challenge: Management of Atrial Thrombus. J Clin Exp Invest. Aralık 2016;7(4):278-282. doi:10.5799/jcei.328366
Chicago Burç Deşer, Serkan, ve Mustafa Kemal Demirağ. “A Therapeutic Challenge: Management of Atrial Thrombus”. Journal of Clinical and Experimental Investigations 7, sy. 4 (Aralık 2016): 278-82. https://doi.org/10.5799/jcei.328366.
EndNote Burç Deşer S, Demirağ MK (01 Aralık 2016) A Therapeutic Challenge: Management of Atrial Thrombus. Journal of Clinical and Experimental Investigations 7 4 278–282.
IEEE S. Burç Deşer ve M. K. Demirağ, “A Therapeutic Challenge: Management of Atrial Thrombus”, J Clin Exp Invest, c. 7, sy. 4, ss. 278–282, 2016, doi: 10.5799/jcei.328366.
ISNAD Burç Deşer, Serkan - Demirağ, Mustafa Kemal. “A Therapeutic Challenge: Management of Atrial Thrombus”. Journal of Clinical and Experimental Investigations 7/4 (Aralık 2016), 278-282. https://doi.org/10.5799/jcei.328366.
JAMA Burç Deşer S, Demirağ MK. A Therapeutic Challenge: Management of Atrial Thrombus. J Clin Exp Invest. 2016;7:278–282.
MLA Burç Deşer, Serkan ve Mustafa Kemal Demirağ. “A Therapeutic Challenge: Management of Atrial Thrombus”. Journal of Clinical and Experimental Investigations, c. 7, sy. 4, 2016, ss. 278-82, doi:10.5799/jcei.328366.
Vancouver Burç Deşer S, Demirağ MK. A Therapeutic Challenge: Management of Atrial Thrombus. J Clin Exp Invest. 2016;7(4):278-82.